
uMotif
A platform to track health and share data with doctors, carers, family and friends making it easy for everyone.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
* | $25.5m | Late VC | |
Total Funding | 000k |
USD | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | - | 88 % | 47 % | 40 % | 72 % | - |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
uMotif operates in the healthcare technology sector, providing a patient-centric data capture platform designed to support virtual clinical trials. The platform is utilized by leading academics, Contract Research Organizations (CROs), biotechs, medical device companies, and pharmaceutical firms. uMotif's technology captures various types of data including electronic Clinical Outcome Assessments (eCOA), electronic Patient-Reported Outcomes (ePRO), eDiaries, eConsent, symptom tracking, and wearable device data. The platform is designed to be user-friendly and engaging, reducing the burden on patients participating in research studies. Since its inception in 2012, uMotif has been instrumental in powering some of the largest virtual trials globally. The company operates on a B2B (business-to-business) model, generating revenue through licensing its platform to organizations conducting clinical research. The platform is compliant with major regulatory standards such as GCP, 21 CFR Part 11, GDPR, and HIPAA, ensuring data security and integrity.
Keywords: patient-centric, data capture, virtual trials, eCOA, ePRO, eDiaries, eConsent, wearables, healthcare technology, clinical research.